Autopsy report · NCT04355832

Glucagon-like Peptide-1 in Type 1 Diabetes

Cause of deathSlow enrollment Automatic label, confidence 0.5, unverified. How labels are made.

“We were unable to obtain GLP-1”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Early Phase 1
Sponsor: University of Maryland, Baltimore
Sponsor type: University, hospital or other
Conditions: Type1 Diabetes Mellitus
Interventions: Glucagon-like peptide-1; Placebos
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.